De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms
Dr. Rico Buchli and the HLA Protein Technologies team provide answers to questions from their webinar on next-generation soluble HLA peptide discovery platforms to strengthen early immunotherapy R&D.
De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms
In this webinar, Rico Buchli, PhD, shares how next-generation soluble HLA peptide discovery platforms can strengthen early immunotherapy R&D - from target identification and confirmation to receptor/drug validation and translational decision-making.
In Vivo panCAR™ Therapy Using Circular RNA for the Treatment of Autoimmune Disease
Learn how in vivo panCAR™ therapy, based on circular RNA and lipid nanoparticles, enables transient CAR expression and B cell depletion in preclinical models of autoimmune disease.
Industry Insights with Henry Zhu and BPS Bioscience
Henry Zhu, CEO of BPS Bioscience, reflects on 20 years of growth, innovation, and the company’s role in advancing drug discovery research.
Vaccine-Boosting CAR T Cells Against Solid Tumors
Learn how a novel amphiphilic ligand boosts CAR T cells in vivo, enhances tumor targeting, and activates endogenous immunity—offering a promising new strategy for treating solid tumors.
CAR Finder – A Platform for Rapid CAR T Cell Screening
Dr. Sandy Tretbar introduces CAR Finder Technology and shares practical strategies to improve mRNA-based CAR T cell screening and selection.
Next-Generation Cell Isolation Solutions for T Cell Therapy Research
Get expert insights on efficient T cell isolation for therapy research with Drs. Durkin and Antignano in this Q&A Report.
Translational T Cell Talks: Scaling for the Future
Join STEMCELL's Translational T Cell Talks on June 11, 2024 for a half-day event featuring presentations on CAR T cell research, new protocols, educational content, and special promotions.
The Cancer-Immunity Cycle: Methods, Challenges, and Opportunities
In this series, experts provide an overview of technologies, techniques, challenges, and emerging research questions along each step of the cancer immunity cycle.
#ExpertAnswers: Marcela Maus on Inflammation and Immunophysiology
Dr. Marcela Maus discusses the components and technologies used in making a T cell product, important considerations for efficacy, and underlying mechanisms of toxicity and resistance.
Engineered T Cells for Cancer
Dr. Marcela Maus discusses CAR T Cell research, the components and technologies used in making a T cell product, important considerations for efficacy, and underlying mechanisms of toxicity and resistance.
Inflammation & Immunophysiology: An Exploration of Pathophysiology
Inflammation & Immunophysiology: A webinar series covering fundamentals, late-breaking research and novel discoveries in the field of immunophysiology and inflammation sciences.
